| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.34 | 0.02 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.02 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.02 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.099 | 0.02 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |